Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
Study NCT ID:
NCT06673368
Status:
RECRUITING
Last Update Posted:
2025-03-12
First Post:
2024-11-01
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Sponsor:
Neurocentria, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-01
First Submit QC Date:
None
Study First Post Date:
2024-11-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-07
Last Update Post Date:
2025-03-12
Last Update Post Date Type:
ACTUAL